Lupus anticoagulant in patients with COVID‐19
Open Access
- 11 September 2020
- journal article
- letter
- Published by Wiley in International Journal of Laboratory Hematology
- Vol. 43 (1) , E17-E18
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19New England Journal of Medicine, 2020
- Incidence of thrombotic complications in critically ill ICU patients with COVID-19Thrombosis Research, 2020
- Lupus anticoagulant is frequent in patients with Covid‐19Journal of Thrombosis and Haemostasis, 2020
- Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathyJournal of Thrombosis and Haemostasis, 2020
- Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumoniaJournal of Thrombosis and Haemostasis, 2020
- Risk of developing antiphospholipid antibodies following viral infection: a systematic review and meta-analysisLupus, 2017
- Severe acute respiratory syndrome and lupus anticoagulants in childrenBritish Journal of Haematology, 2003